YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Autologous Tumor Infiltrating Lymphocytes in Patients With Pretreated Metastatic Triple Negative Breast Cancer

Phase 2

Completed

Conditions: Metastatic Triple Negative Breast Cancer

Interventions: Drug: Tumor infiltrating lymphocytes (TIL) LN-145

First Posted Date: 2019-10-01

Last Posted Date: 2024-11-21

Lead Sponsor: Yale University

Target Recruit Count: 6

Registration Number: NCT04111510

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

CPX-351 in Patients Treated for Higher-risk Myelodysplastic Syndromes Experiencing Hypomethylating Agent Failure.

Phase 1

Withdrawn

Conditions: MDS

Interventions: Drug: CPX-351

First Posted Date: 2019-09-30

Last Posted Date: 2022-01-24

Lead Sponsor: Yale University

Registration Number: NCT04109690

Locations: 🇺🇸
Yale University; Smilow Cancer Center, New Haven, Connecticut, United States

A Digital Intervention to Prevent Initiation of Opioid Misuse in Adolescents in School-based Health Centers

Not Applicable

Completed

Conditions: Opioid Misuse

Interventions: Behavioral: PlaySmart
Behavioral: PlaySmart Storyline
Behavioral: Play Smart Mini-Game

First Posted Date: 2019-09-30

Last Posted Date: 2022-07-08

Lead Sponsor: Yale University

Target Recruit Count: 33

Registration Number: NCT04109599

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

A Digital Intervention for HIV Prevention in Black Adolescent Girls

Not Applicable

Completed

Conditions: Risk Reduction Behavior
HIV

Interventions: Other: Non-Health Related Video Game
Behavioral: InvestiDate

First Posted Date: 2019-09-30

Last Posted Date: 2023-11-08

Lead Sponsor: Yale University

Target Recruit Count: 117

Registration Number: NCT04108988

Locations: 🇺🇸
Kimberly Hieftje, New Haven, Connecticut, United States

Promoting Reductions in Intersectional StigMa (PRISM) - GHANA

Not Applicable

Completed

Conditions: Stigma
HIV

Interventions: Behavioral: Health Policy Plus (HP+)
Behavioral: Many Men Many Voices (3MV)
Behavioral: HIV Education, Empathy and Empowerment (HIVE3)

First Posted Date: 2019-09-27

Last Posted Date: 2023-03-06

Lead Sponsor: Yale University

Target Recruit Count: 549

Registration Number: NCT04108078

Locations: 🇬🇭
University of Ghana School of Public Health, Accra, Greater Accra Region, Ghana

The Use of Ultrasound in Nasogastric Tube Placement in Children Admitted to the Pediatric ICU

Not Applicable

Withdrawn

Conditions: Nasogastric Tube

Interventions: Diagnostic Test: Ultrasound following X-ray

First Posted Date: 2019-09-26

Last Posted Date: 2021-04-20

Lead Sponsor: Yale University

Registration Number: NCT04104295

Pathogenesis of the Cardiometabolic Risk in Youth With Type 1 Diabetes

Not Applicable

Terminated

Conditions: De Novo Lipogenesis
Type 1 Diabetes

Interventions: Diagnostic Test: Oral Glucose Tolerance Test

First Posted Date: 2019-09-24

Last Posted Date: 2023-02-13

Lead Sponsor: Yale University

Target Recruit Count: 7

Registration Number: NCT04101045

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Cognitive Behavioral Therapy for Adolescent Binge Eating and Loss of Control Eating

Not Applicable

Completed

Conditions: Binge Eating
Overweight and Obesity
Eating Disorders in Adolescence

Interventions: Behavioral: Cognitive-Behavioral Therapy for Adolescent Binge/Loss-of-Control Eating
Other: Control Condition

First Posted Date: 2019-09-12

Last Posted Date: 2024-10-10

Lead Sponsor: Yale University

Target Recruit Count: 50

Registration Number: NCT04088097

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

Very Low Carbohydrate Diet as an Adjunctive Therapy for Youth Type 1 Diabetes

Not Applicable

Completed

Conditions: Type 1 Diabetes

Interventions: Behavioral: Very Low Carbohydrate Diet

First Posted Date: 2019-09-09

Last Posted Date: 2024-02-15

Lead Sponsor: Yale University

Target Recruit Count: 6

Registration Number: NCT04082884

Locations: 🇺🇸
Yale-New Haven Hospital, New Haven, Connecticut, United States

Postoperative Dexamethasone on Post-Cesarean Pain

Phase 4

Recruiting

Conditions: Post-Cesarean Pain
Cesarean Section Complications

Interventions: Other: placebo
Drug: Dexamethasone

First Posted Date: 2019-08-26

Last Posted Date: 2024-02-07

Lead Sponsor: Yale University

Target Recruit Count: 40

Registration Number: NCT04067609

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy